Although the insertion of inferior vena cava filters declined between 2013 and 2021, the rate of retrievals remained low, ...

Character Biosciences announced a collaboration with Bausch + Lomb with an initial focus on developing innovative treatments ...

Resveratrol supplementation with selective laser trabeculoplasty may be an effective treatment option for glaucoma by ...

Characteristics of shoulder instability may be identified by distinct imaging features on MRI, MR arthrography and CT, ...

The FDA approved the phase 2 Explore-OSA trial set to assess the highly selective aldosterone synthase inhibitor, ...

Individuals with negative colonoscopy screening results had lower long-term risk for colorectal cancer and related mortality, ...

Patients with relapsed or refractory large B-cell lymphoma who received epcoritamab or glofitamab in real-world settings ...

Topical ET-02 demonstrated successful results in its first-in-human clinical trial for the treatment of androgenic alopecia, Eirion Therapeutics announced in a press release. “Right now, 80 million ...

As physicians, we have all borne witness to patients dying at a young age, whether from an unforeseen illness or injury.

The Health Resources and Services Administration announced $60 million in funding to expand the hours of operation for 125 ...

More than one in 10 children worldwide reported experiencing sexual violence, according to a large meta-analysis published in ...

The FDA has proposed a rule requiring a new nutrition label on the front of most packaged foods, offering consumers easily ...